[{"Assets_0_Q2_USD":2023344000.0,"CIK":"1293971","CommonStockSharesConverted_0_Q2_shares":55228000.0,"CommonStockSharesOutstanding_0_Q2_shares":55228000.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":-3.55,"EarningsPerShareBasic_2_Q2_USD":-6.54,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"301448421.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-292027000.0,"NetIncomeLossConverted_1_Q2_USD":-195782000.0,"NetIncomeLossConverted_2_Q2_USD":-360228000.0,"OfficialName":"bluebird bio Inc. Common Stock","RevenuesConverted_1_Q2_USD":13296000.0,"RevenuesConverted_2_Q2_USD":25767000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q2_USD":1636374000.0,"Ticker":"BLUE","filed":"20190801","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2019.0","name":"BLUEBIRD BIO, INC.","period":"20190630","qtrs":"0","uom":"USD"}]